SCHEMBL19863149

SCHEMBL19863149

CC1(C)OB(c2cc3c4ccccc4oc3c3[nH]c4ccccc4c23)OC1(C)C

nearest known ligand 0.41

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ MAP3K11 Q16584 2/20 0.41
▸ MAP3K9 P80192 1/20 0.41
▸ CDK5 Q00535 4/20 0.37
▸ CDK5R1 Q15078 3/20 0.37
▸ DYRK1A Q13627 3/20 0.37
▸ MEN1 O00255 4/20 0.35
▸ KMT2A Q03164 4/20 0.35
▸ POLB P06746 1/20 0.35
▸ PPARG P37231 1/20 0.35
▸ RAB9A P51151 1/20 0.35
▸ NCOA2 Q15596 1/20 0.35
▸ NCOA1 Q15788 1/20 0.35
▸ L3MBTL1 Q9Y468 1/20 0.35
▸ MAPT P10636 2/20 0.35
▸ GSK3A P49840 1/20 0.34
▸ GSK3B P49841 1/20 0.34
▸ CDK4 P11802 2/20 0.33
▸ CCND1 P24385 2/20 0.33
▸ CAMK2B Q13554 2/20 0.33
▸ CAMK2G Q13555 2/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL19863150 0.91 MAP3K11 (0.38) MAP3K11MAP3K9CDK5CDK5R1DYRK1A
SCHEMBL19866498 0.88 MAP3K11 (0.34) MAP3K11MAP3K9CDK5CDK5R1DYRK1A
SCHEMBL19863151 0.85 LPL (0.33) MAP3K11MAP3K9RAB9AL3MBTL1GSK3B
SCHEMBL19863148 0.85 ALDH1A1 (0.34) MEN1KMT2ARAB9AL3MBTL1MAPT
SCHEMBL17382529 0.78 MEN1 (0.41) DYRK1AMEN1KMT2ARAB9AMAPT
SCHEMBL17524700 0.77 MEN1 (0.53) MAP3K11MAP3K9CDK5CDK5R1DYRK1A
SCHEMBL19045125 0.75 JAK2 (0.39) MAP3K11MAP3K9MEN1KMT2ARAB9A
SCHEMBL18593650 0.75 AHR (0.55) MAP3K11MAP3K9CDK5CDK5R1DYRK1A
SCHEMBL21186700 0.75 LPL (0.33) MEN1KMT2AL3MBTL1MAPTAHR
SCHEMBL24126484 0.74 KMT2A (0.39) MEN1KMT2APPARGL3MBTL1CYP2C19

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20180047914-A1 HETEROCYCLIC COMPOUND AND ORGANIC LIGHT EMITTING ELEMENT COMPRISING SAME LG CHEM, LTD. (KR) 2018-02-15 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20180047914-A1 HETEROCYCLIC COMPOUND AND ORGANIC LIGHT EMITTING ELEMENT COMPRISING SAME CRY1, CRY2, NR2E3 MAP3K11 3863/4885MAP3K9 3934/4885CDK5 753/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback